Does bone resorption inhibition affect the anabolic response to parathyroid hormone?
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 15 (2) , 49-50
- https://doi.org/10.1016/j.tem.2004.01.002
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Effects of Parathyroid Hormone, Alendronate, or Both in Men with OsteoporosisNew England Journal of Medicine, 2003
- The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal OsteoporosisNew England Journal of Medicine, 2003
- Parathyroid Hormone plus Alendronate — A Combination That Does Not Add UpNew England Journal of Medicine, 2003
- Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugsThe American Journal of Medicine, 2002
- Catabolic Effects of Continuous Human PTH (1-38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone FormationEndocrinology, 2001
- Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2001
- Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormoneJournal of Clinical Investigation, 1999
- Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cellsEndocrinology, 1995